CD40/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory molecules

Journal of Immunology

Volumn 189, Issue 9, 2012, Pages 4387-4395

  Ferrer, Ivana R ^a   Liu, Danya ^a   Pinelli, David F ^a   Koehn, Brent H ^a   Stempora, Linda L ^a   Ford, Mandy L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; COSTIMULATORY MOLECULE; GLYCOPROTEIN P 15095; INTERLEUKIN 12P40; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN; OVALBUMIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CHIMERA; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD40; CD40 LIGAND; CHICKENS; CYTOKINES; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; INFLAMMATION MEDIATORS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RADIATION CHIMERA; SIGNAL TRANSDUCTION;

EID: 84867911452     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201757     Document Type: Article

References (37)

1. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434-438. (Pubitemid 26162734)
2. Hancock, W. W., M. H. Sayegh, X. G. Zheng, R. Peach, P. S. Linsley, and L. A. Turka. 1996. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA 93: 13967-13972. (Pubitemid 26424229)
3. Kirk, A. D., L. C. Burkly, D. S. Batty, R. E. Baumgartner, J. D. Berning, K. Buchanan, J. H. Fechner, Jr., R. L. Germond, R. L. Kampen, N. B. Patterson, et al. 1999. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. 5: 686-693. (Pubitemid 29289433)
4. Kirk, A. D., D. M. Harlan, N. N. Armstrong, T. A. Davis, Y. Dong, G. S. Gray, X. Hong, D. Thomas, J. H. Fechner, Jr., and S. J. Knechtle. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94: 8789-8794. (Pubitemid 27335118)
5. Markees, T. G., N. E. Phillips, E. J. Gordon, R. J. Noelle, L. D. Shultz, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 1998. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J. Clin. Invest. 101: 2446-2455. (Pubitemid 28270439)
6. Kawai, T., D. Andrews, R. B. Colvin, D. H. Sachs, and A. B. Cosimi. 2000. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat. Med. 6: 114. (Pubitemid 30082329)
7. Badell, I. R., P. W. Thompson, A. P. Turner, M. C. Russell, J. G. Avila, J. A. Cano, J. M. Robertson, F. V. Leopardi, B. E. Jonhson, E. A. Strobert, et al. 2012. Non-depleting CD40-specific therapy prolongs allograft survival in non-human primates. Am. J. Transplant. 12: 126-135.
8. Page, A., S. Srinivasan, K. Singh, M. Russell, K. Hamby, T. Deane, S. Sen, L. Stempora, F. Leopardi, A. A. Price, et al. 2012. CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model. Am. J. Transplant. 12: 115-125.
9. Thompson, P., K. Cardona, M. Russell, I. R. Badell, V. Shaffer, G. Korbutt, G. R. Rayat, J. Cano, M. Song, W. Jiang, et al. 2011. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am. J. Transplant. 11: 947-957.
10. Oura, T., K. Yamashita, T. Suzuki, D. Fukumori, M. Watanabe, G. Hirokata, K. Wakayama, M. Taniguchi, T. Shimamura, T. Miura, et al. 2012. Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates. Am. J. Transplant. 12: 1740-1754.
11. Monk, N. J., R. E. Hargreaves, J. E. Marsh, C. A. Farrar, S. H. Sacks, M. Millrain, E. Simpson, J. Dyson, and S. Jurcevic. 2003. Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat. Med. 9: 1275-1280. (Pubitemid 37279850)
12. Adams, A. B., N. Shirasugi, T. R. Jones, M. M. Durham, E. A. Strobert, S. Cowan, P. Rees, R. Hendrix, K. Price, N. S. Kenyon, et al. 2005. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J. Immunol. 174: 542-550. (Pubitemid 40007445)
13. Haanstra, K. G., J. Ringers, E. A. Sick, S. Ramdien-Murli, E. M. Kuhn, L. Boon, and M. Jonker. 2003. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates. Transplantation 75: 637-643. (Pubitemid 36337361)
14. Gilson, C. R., Z. Milas, S. Gangappa, D. Hollenbaugh, T. C. Pearson, M. L. Ford, and C. P. Larsen. 2009. Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation. J. Immunol. 183: 1625-1635.
15. Säemann, M. D., C. Diakos, P. Kelemen, E. Kriehuber, M. Zeyda, G. A. Böhmig, W. H. Hörl, T. Baumruker, and G. J. Zlabinger. 2003. Prevention of CD40-triggered dendritic cell maturation and induction of T-cell hyporeactivity by targeting of Janus kinase 3. Am. J. Transplant. 3: 1341-1349. (Pubitemid 37288077)
16. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252. (Pubitemid 28155090)
17. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811. (Pubitemid 30365397)
18. Hochweller, K., and S. M. Anderton. 2005. Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivo. Eur. J. Immunol. 35: 1086-1096. (Pubitemid 40542215)
19. van Kooten, C., and J. Banchereau. 2000. CD40-CD40 ligand. J. Leukoc. Biol. 67: 2-17. (Pubitemid 30046812)
20. Miga, A. J., S. R. Masters, B. G. Durell, M. Gonzalez, M. K. Jenkins, C. Maliszewski, H. Kikutani, W. F. Wade, and R. J. Noelle. 2001. Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions. Eur. J. Immunol. 31: 959-965. (Pubitemid 32237132)
21. De Smedt, T., B. Pajak, G. G. Klaus, R. J. Noelle, J. Urbain, O. Leo, and M. Moser. 1998. Antigen-specific T lymphocytes regulate lipopolysaccharideinduced apoptosis of dendritic cells in vivo. J. Immunol. 161: 4476-4479. (Pubitemid 28492014)
22. Ehst, B. D., E. Ingulli, and M. K. Jenkins. 2003. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am. J. Transplant. 3: 1355-1362. (Pubitemid 37288079)
23. Curtsinger, J. M., C. M. Johnson, and M. F. Mescher. 2003. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 171: 5165-5171. (Pubitemid 37432800)
24. Curtsinger, J. M., D. C. Lins, and M. F. Mescher. 2003. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197: 1141-1151. (Pubitemid 36570069)
25. Curtsinger, J. M., C. S. Schmidt, A. Mondino, D. C. Lins, R. M. Kedl, M. K. Jenkins, and M. F. Mescher. 1999. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J. Immunol. 162: 3256-3262. (Pubitemid 29313572)
26. Joshi, N. S., W. Cui, A. Chandele, H. K. Lee, D. R. Urso, J. Hagman, L. Gapin, and S. M. Kaech. 2007. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295. (Pubitemid 47284924)
27. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
28. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-480.
29. Ridge, J. P., F. Di Rosa, and P. Matzinger. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393: 474-478.
30. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
31. Kobayashi, T., P. T.Walsh, M. C. Walsh, K. M. Speirs, E. Chiffoleau, C. G. King, W. W. Hancock, J. H. Caamano, C. A. Hunter, P. Scott, et al. 2003. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 19: 353-363. (Pubitemid 37153412)
32. Zhao, X., O. Boenisch, M. Yeung, B. Mfarrej, S. Yang, L. A. Turka, M. H. Sayegh, J. Iacomini, and X. Yuan. 2012. Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am. J. Transplant. 12: 90-101.
33. Booth, A. J., S. Grabauskiene, S. C. Wood, G. Lu, B. E. Burrell, and D. K. Bishop. 2011. IL-6 promotes cardiac graft rejection mediated by CD4+ cells. J. Immunol. 187: 5764-5771.
34. Chen, L., E. Ahmed, T. Wang, Y. Wang, J. Ochando, A. S. Chong, and M. L. Alegre. 2009. TLR signals promote IL-6/IL-17-dependent transplant rejection. J. Immunol. 182: 6217-6225.
35. Shen, H., and D. R. Goldstein. 2009. IL-6 and TNF-alpha synergistically inhibit allograft acceptance. J. Am. Soc. Nephrol. 20: 1032-1040.
36. Ruedl, C., M. Kopf, and M. F. Bachmann. 1999. CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivo. J. Exp. Med. 189: 1875-1884.
37. Min, L., S. A. Mohammad Isa, W. Shuai, C. B. Piang, F. W. Nih, M. Kotaka, and C. Ruedl. 2010. Cutting edge: granulocyte-macrophage colony-stimulating factor is the major CD8+ T cell-derived licensing factor for dendritic cell activation. J. Immunol. 184: 4625-4629.